Home | Community | Get Involved | Donate | | Site Index | Search Go Button
The mark, American Cancer Society, is a registered trademark of the American Cancer Society, Inc., and may not be copied, reproduced, transmitted, displayed, performed, distributed, sublicensed, altered, stored for subsequent use or otherwise used in whole or in part in any manner without ACS's prior written consent.
 
My Planner Register | Sign In Sign In


Cancer Reference Information
 
    All About This Topic
Other Information Sources
Glossary
Cancer Drug Guide
Treatment Options
Treatment Decision Tools
   
Detailed Guide: Retinoblastoma
What Are the Key Statistics for Retinoblastoma?

Retinoblastoma is a rare disease. Only about 300 children are diagnosed with retinoblastoma each year in the United States. It is more common in infants and very young children than in older children. The average age of children when they are diagnosed is 2. It rarely occurs in children older than 6.

About 2 out of 3 children with retinoblastoma have a tumor in only one eye. In about 1 case in 3, both eyes are affected.

Retinoblastoma occurs about equally in boys and girls and in different races and ethnicities. It also occurs equally in the right or left eye.

Overall, more than 90% of children with retinoblastoma can be cured, although this outlook is not nearly as good if the cancer has spread to other parts of the body.

Last Medical Review: 10/26/2009
Last Revised: 10/26/2009

Printer-Friendly Page
Email this Page
Detailed Guide
What Is It?
Causes, Risk Factors and Prevention
Early Detection, Diagnosis, Staging
Treating Retinoblastoma
Talking With Your Doctor
More Information
Related Tools & Topics
Prevention & Early Detection  
Bookstore  
Circle Of Sharing: Personalize Your Cancer Information  
Not registered yet?
  Register now or see reasons to register.  
Help |  About ACS |  Employment & Volunteer Opportunities |  Legal & Privacy Information |  Press Room
Copyright 2009 © American Cancer Society, Inc.
All content and works posted on this website are owned and
copyrighted by the American Cancer Society, Inc. All rights reserved.